Thursday, May 23, 2013

Shazam Revamps Its iPad App For Second Screen Action, Can Now ?AutoTag? In Background While You Watch TV

iPad Retina GUI PSDAlthough the majority of?Shazam‘s over 93 million U.S. users still use the app on their smartphones to identify, tag and share the songs they’re “hearing,” a growing chunk of that user base – around 10 million in the U.S. last year – has used Shazam to identify TV programs and ads. Today, the company aims to better serve this audience with the release of a new, universal iOS application which introduces a number of new features, including the ability to have the “shazaming” process run automatically in the background. This feature, called “Auto-Tagging,” is the standout in today’s release. Before, users had to kick off the tagging option by tapping on the screen, then waiting while Shazam listened and then identified the sounds they were hearing, whether that was music, a TV show or a TV ad. While that’s still how things will work on the smartphone version, the updated iPad app now offers a more passive experience, designed for those using the app as a second screen while watching TV. Notably, the feature will not be switched on by default. Instead, after downloading the updated version, users will be walked through a brief tutorial that explains what Auto-Tagging is all about, then allowing users to switch it on, if desired. If they do so, the app will run in the background, listening for anything it can identify, and loading those items into a?carousel at the top of its homescreen. From here, users can interact with the content much as before – sharing it on social media, buying the song, show or movie from iTunes or Amazon, or in the case of TV shows, learning more about the cast and episode, viewing a playlist of songs in the broadcast, ?or heading off to sites like Wikipedia, IMDb, the official website and/or store, and more. Some TV shows will work continue to work with the company to offer enhanced experiences, like “American Idol” had done in the past, and “The Voice” is doing now. These experiences are generally offered to TV show producers for free, with the stipulation that they have to promote Shazam on air. However, the Fiat Brand and Fox Broadcasting Company are sponsoring the new app for the first three months after today’s debut, which is a paid relationship. “Auto-tagging sets us apart from the industry,” explains Shazam’s?EVP of Marketing, David Jones of the app’s big new feature.

Source: http://feedproxy.google.com/~r/Techcrunch/~3/-ly6PU_3LUI/

julio jones j crew san francisco 49ers san francisco 49ers stan musial Mega 49ers

Amazon launches Kindle Worlds publishing platform for fan fiction, will pay royalties to writers and rights holders

Amazon launches Kindle Worlds publishing platform for fan fiction, will pay royalties to writers and rights holders

Amazon's taken a number of steps to bring different types of content to the Kindle Store, and it's now venturing into an area that has a long history with the internet: fan fiction. The company's today announced Kindle Worlds, a new publishing platform that promises to pay writers royalties for stories inspired by established works. Naturally, the original rights holder needs to be a willing participant as well, and they'll also be paid a royalty for all fan fiction stories sold (Amazon itself with retain the rights to those stories). So what are your options for now? For the launch, Amazon has partnered with Warner Bros. Television Group's Alloy Entertainment to open up three of its series to fan fiction enthusiasts, giving you the chance to write stories set in the world of Gossip Girl, Pretty Little Liars or The Vampire Diaries. The company's promising that additional licenses are on the way, but for now you can check out the finer details in the press release after the break and at the source link below.

Filed under:

Comments

Source: Kindle Worlds

Source: http://www.engadget.com/2013/05/22/amazon-kindle-worlds-fan-fiction/?utm_medium=feed&utm_source=Feed_Classic&utm_campaign=Engadget

celebrity apprentice Jodi Arias Trial Live Bay to Breakers Andrea Rebello wfaa prince christina aguilera

Wednesday, May 22, 2013

Advance in nanotech gene sequencing technique

Tuesday, May 21, 2013

The allure of personalized medicine has made new, more efficient ways of sequencing genes a top research priority. One promising technique involves reading DNA bases using changes in electrical current as they are threaded through a nanoscopic hole.

Now, a team led by University of Pennsylvania physicists has used solid-state nanopores to differentiate single-stranded DNA molecules containing sequences of a single repeating base.

The study was led by Marija Drndi?, an associate professor in the Department of Physics and Astronomy in the School of Arts and Sciences, along with graduate students Kimberly Venta and Matthew Puster and post-doctoral researchers Gabriel Shemer, Julio A. Rodriguez-Manzo and Adrian Balan. They collaborated with assistant professor Jacob K. Rosenstein of Brown University and professor Kenneth L. Shepard of Columbia University.

Their results were published in the journal ACS Nano.

In this technique, known as DNA translocation measurements, strands of DNA in a salt solution are driven through an opening in a membrane by an applied electric field. As each base of the strand passes through the pore, it blocks some ions from passing through at the same time; amplifiers attached to the nanopore chip can register the resulting drop in electrical current. Because each base has a different size, researchers hope to use this data to infer the order of the bases as the strand passes through. The differences in base sizes are so small, however, that the proportions of both the nanopores and membranes need to be close those of the DNA strands themselves ? a major challenge.

The nanopore devices closest to being a commercially viable option for sequencing are made out of protein pores and lipid bilayers. Such protein pores have desirable proportions, but the lipid bilayer membranes in which they are inserted are akin to a film of soap, which leaves much to be desired in terms of durability and robustness.

Solid-state nanopore devices, which are made of thin solid-state membranes, offer advantages over their biological counterparts ? they can be more easily shipped and integrated with other electronics ? but the basic demonstrations of proof-of-principle sensitivity to different DNA bases have been slower.

"While biological nanopores have shown the ability to resolve single nucleotides, solid-state alternatives have lagged due to two challenges of actually manufacturing the right-sized pores and achieving high-signal, low-noise and high-bandwidth measurements," Drndi? said. "We're attacking those two challenges here."

Because the mechanism by which the nanopore differentiate between one type of base and another is by the amount of the pore's aperture that is blocked, the smaller a pore's diameter, the more accurate it is. For the nanopore to be effective at determining a sequence of bases, its diameter must approach the diameter of the DNA and its thickness must approach that of the space between one base and the next, or about 0.3 nanometers.

To get solid-state nanopores and membranes in these tiny proportions, researchers, including Drndi?'s group, are investigating cutting-edge materials, such as graphene. A single layer of carbon atoms in a hexagonal lattice, graphene membranes can be made a little as about 0.5 nanometers thick but have their own disadvantages to be addressed. For example, the material itself is hydrophobic, making it more difficult to pass strands of DNA through them.

In this experiment, Drndi? and her colleagues worked with a different material ? silicon nitride ? rather than attempting to craft single-atom-thick graphene membranes for nanopores. Treated silicon nitride is hydrophilic and has readily allowed DNA translocations, as measured by many other researchers during the last decade. And while their membrane is thicker, about 5 nanometers, silicon nitride pores can also approach graphene in terms of thinness due to the way they are manufactured.

"The way we make the nanopores in silicon nitride makes them taper off, so that the effective thickness is about a third of the rest of the membrane," Drndi? said.

Drndi? and her colleagues tested their silicon nitride nanopore on homopolymers, or single strands of DNA with sequences that consist of only one base repeated several times. The researchers were able to make distinct measurements for three of the four bases: adenine, cytosine and thymine. They did not attempt to measure guanine as homopolymers made with that base bind back on themselves, making it more difficult to pass them through the nanopores.

"We show that these small pores are sensitive to the base content," Drndi? said, "and we saw these results in pores with diameters between 1 and 2 nanometers, which is actually encouraging because it suggests some manufacturing variability may be okay."

###

University of Pennsylvania: http://www.upenn.edu/pennnews

Thanks to University of Pennsylvania for this article.

This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.

This press release has been viewed 45 time(s).

Source: http://www.labspaces.net/128328/Advance_in_nanotech_gene_sequencing_technique

mexico earthquake aziz ansari aziz ansari katherine jenkins peyton manning broncos mexico city earthquake stand your ground law

NFL on notice: Brady feeling better

Tampa Bay Buccaneers v Carolina PanthersGetty Images

If Buccaneers coach Greg Schiano ever gets tired of having to tell people Josh Freeman is his starting quarterback, someone should probably mention to him that it?s kind of his own fault.

Schiano started singing like Tammy Wynette again in relation to Freeman Monday, the day after he was quoted as saying he was ?not against? the notion of starting rookie Mike Glennon instead.

?We have a starting quarterback, and it?s Josh Freeman,? Schiano said, via Stephen Holder of the Tampa Bay Times.

According to the report, Schiano said he?s trying to be honest, and doesn?t mean to put pressure on Freeman by saying such things in the national media.

?I guess nationally, they don?t sit here with me every day like you guys [local media] do,? Schiano said. ?From the day we arrived, our whole program has [been based on] competition, . . . That?s what we believe in. It?s the most competitive sports league in the world. It?s competition, and I love it.

?But we have our starting quarterback, and it?s Josh Freeman. I?m not looking to find another.?

If he really wanted to clear things up, he could always, you know, stop leaving the door open a crack every time he talks about Glennon.

Or, if he wanted a stronger statement on Freeman and how much he loves him under center, he could give him a new contract to replace the final year of his rookie deal.

But it doesn?t appear at the moment that Schiano intends to do either.

And that?s fine, as long as everyone?s clear about the implication sent by those actions.

He likes Freeman, right up until the point he decides he doesn?t.

So Schiano?s apparently going to have to keep clarifying all the things that he keeps saying, whether to the national or local media.

Source: http://profootballtalk.nbcsports.com/2013/05/20/tom-brady-im-more-confident-than-ever-throwing-the-football/related/

masters par 3 gwen stefani overeem laron landry mary j blige burger king islands 2013 nissan altima

Tuesday, May 21, 2013

Justin Bieber And Miley Cyrus: An Item In The Studio?

At Sunday night's Billboard Music Awards, Cyrus addresses rumors she and Bieber are working on music together.
By Jocelyn Vena

Source: http://www.mtv.com/news/articles/1707654/miley-cyrus-justin-bieber-studio-collaboration.jhtml

bill cosby us open bill nye Hurricane Isaac 2012 Snooki Baby terrell owens terrell owens

Resistance to last-line antibiotic makes bacteria resistant to immune system

May 21, 2013 ? Bacteria resistant to the antibiotic colistin are also commonly resistant to antimicrobial substances made by the human body, according to a study in mBio?, the online open-access journal of the American Society for Microbiology. Cross-resistance to colistin and host antimicrobials LL-37 and lysozyme, which help defend the body against bacterial attack, could mean that patients with life-threatening multi-drug resistant infections are also saddled with a crippled immune response. Colistin is a last-line drug for treating several kinds of drug-resistant infections, but colistin resistance and the drug's newfound impacts on bacterial resistance to immune attack underscore the need for newer, better antibiotics.

Corresponding author David Weiss of Emory University says the results show that colistin therapy can fail patients in two ways. "The way that the bacteria become resistant [to colistin] allows them to also become resistant to the antimicrobials made by our immune system. That is definitely not what doctors want to do when they're treating patients with this last line antibiotic," says Weiss.

Although it was developed fifty years ago, colistin remains in use today not so much because it's particularly safe or effective, but because the choices for treating multi-drug resistant Acinetobacter baumannii and other resistant infections are few and dwindling. Colistin is used when all or almost all other drugs have failed, often representing a patient's last hope for survival.

Weiss says he and his colleagues noted that colistin works by disrupting the inner and outer membranes that hold Gram-negative bacterial cells together, much the same way two antimicrobials of the human immune system, LL-37 and lysozyme, do. LL-37 is a protein found at sites of inflammation, whereas lysozyme is found in numerous different immune cells and within secretions like tears, breast milk, and mucus, and both are important defenses against invading bacteria. Weiss and his collaborators from Emory, the CDC, Walter Reed Army Institute of Research, and Grady Memorial Hospital in Atlanta set out to find whether resistance to colistin could engender resistance to attack by LL-37 or lysozyme.

Looking at A. baumannii isolates from patients around the country, they noted that all the colistin-resistant strains harbored mutations in pmrB, a regulatory gene that leads to the modification of polysaccharides on the outside of the cell in response to antibiotic exposure. Tests showed a tight correlation between the ability of individual isolates to resist high concentrations of colistin and the ability to resist attacks by LL-37 or lysozyme.

This was very convincing, write the authors, that mutations in the pmrB gene were responsible for cross-resistance to LL-37 and lysozyme, but to get closer to a causative link between treatment and cross-resistance, they studied two pairs of A. baumannii isolates taken from two different patients before and after they were treated for three or six weeks with colistin. The results helped confirm the cross-resistance link: neither strain taken before treatment was resistant to colistin, LL-37, or lysozyme, but the strains taken after treatment showed significant resistance to colistin and lysozyme. (One post-colistin isolate was no more or less resistant to LL-37 than its paired pre-colistin isolate.) Like the resistant strains tested earlier, both post-colistin isolates harbored crucial mutations in the pmrB gene that apparently bestow the ability to resist treatment.

The authors point out that the apparent link between resistance to colistin and cross-resistance to antimicrobial agents of the immune system could well extend to other pathogens that are treated with colistin, including Pseudomonas aeruginosa and Klebsiella pneumoniae. Weiss says he plans to follow up with studies to determine whether this bears out.

For Weiss, the problems with colistin are symptomatic of a much larger trio of problems: increasing levels of drug resistance, cuts in federal funding for antibiotic research, and lack of incentives for pharmaceutical companies to invest in antibiotic R&D. "We don't have enough antibiotics, and it's really important for the research community and the public to support increases in funding for research to develop new antibiotics," says Weiss.

"We got complacent for a while and the bugs are becoming resistant. This is something we can reverse -- or make a lot better -- if we have the resources."

Source: http://feeds.sciencedaily.com/~r/sciencedaily/~3/GvkR-4TrerQ/130521011230.htm

joe biden michelle obama lupe fiasco jason wu jason wu Mavericks Surf Stonewall

Giants' Vogelsong wins at last but injures hand

SAN FRANCISCO (AP) ? Ryan Vogelsong broke his throwing hand on a swing after pitching himself toward his first win in seven starts, and the San Francisco Giants returned from a terrible road trip to beat the Washington Nationals 8-0 on Monday night.

The right-hander fouled a ball off his right hand in the bottom of the fifth and grimaced in pain while grabbing the hand. He was quickly examined near the batter's box and left the game. The Giants later announced the injury, without immediately providing any other details.

Vogelsong (2-4) snapped a six-start winless stretch with just his second victory of 2013 and first since April 11 against the Cubs at Wrigley Field and seemed back on track.

He walked off to warm ovation as Nick Noonan pinch hit. Vogelsong allowed three hits in five scoreless innings and lowered his ERA from 8.06 to 7.19.

Brandon Belt hit a solo home run, matched his career best with four hits and scored three runs as San Francisco pounded a season-high 17 hits. Angel Pagan hit an RBI double and two-run single for San Francisco, also making a great leaping catch against the center-field wall.

Andres Torres had three hits and drove in a run and Marco Scutaro added an RBI single among his two hits.

Vogelsong got the defensive gem from Pagan when the center fielder slammed into the wall on Adam LaRoche's deep fly in the second.

The 2011 All-Star ended a six-start winless stretch in which he had lost his last two outings and gone 0-3. He was tagged for eight runs ? three earned ? and six hits in two innings for his shortest outing of the year last Wednesday at Toronto.

Javier Lopez took over for Vogelsong in the top of the sixth and received a little bit more warm up time. Three relievers finished for the Giants' sixth shutout. San Francisco snapped a three-game skid after a 1-5 road trip through Toronto and Colorado.

Bryce Harper went 0 for 4 in his return to the Nationals' lineup after last season's NL Rookie of the Year missed two games with a bruised left knee. He was hurt in a hard collision with the outfield wall a week earlier at Dodger Stadium that also caused him to need 11 stitches on his chin.

Left-hander Zach Duke (0-1) lasted just 3 1-3 innings in a spot start for Ross Detwiler, who is sidelined with back spasms. Duke allowed four runs and seven hits in his first start of the year.

Washington was shut out for the sixth time.

Vogelsong retired the first eight Nationals hitters in order.

The right-hander lasted only 2 2-3 innings in his first career start against Washington last year, allowing eight runs on nine hits with two walks.

Pagan started in center field and batted leadoff after a stomach bug forced him out of Sunday's 5-0 loss at Colorado in the fifth inning.

Third baseman Pablo Sandoval and manager Bruce Bochy also were ill

"I don't know how many guys are catching the crud. Pablo's feeling it, along with myself," Bochy said.

Scutaro extended his hitting streak to 18 games with a third-inning single. The second baseman fielded Roger Bernadina's grounder in the fifth but dropped the ball in exchange from glove to hand, for the Giants' 15th error in their last eight games.

Notes: Nationals OF Jayson Werth, on the 15-day disabled list with a strained right hamstring, is expected to need at least two more weeks to heal after a second MRI showed he "has some problems in there," Johnson said. "He's going to rest a bit." ... A moment of silence was held for the Oklahoma tornado victims before the national anthem. ... RHP Matt Cain (3-2) starts for the Giants in Tuesday night's middle game against righty Stephen Strasburg (2-5). ... San Francisco's Buster Posey has hit safely in 11 of his last 12. ... Belt's homer was the Giants' 21st at home. Last season through their first 23 games at AT&T Park, they had hit just six HRs.

Source: http://news.yahoo.com/giants-vogelsong-wins-last-injures-hand-051341277.html

adrienne rich autism cesar chavez day raspberry ketone ron burgundy millennial media nit championship